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Prevalence of vulvovaginal candidiasis,
bacterial vaginosis and trichomoniasis in
pregnant women attending antenatal clinic
in the middle belt of Ghana
Dennis Gyasi Konadu1*, Alex Owusu-Ofori2,3, Zuwera Yidana1, Farrid Boadu1, Louisa Fatahiya Iddrisu1,
Dennis Adu-Gyasi1, David Dosoo1, Robert Lartey Awuley3ˆ, Seth Owusu-Agyei1,4 and Kwaku Poku Asante1
Abstract
Background: Vaginal infections usually caused by Candida sp, organisms responsible for bacterial vaginosis and
Trichomonas vaginalis are associated with considerable discomfort and adverse outcomes during pregnancy and
child birth. The study determined the prevalence of vulvovaginal candidiasis (VVC), bacterial vaginosis (BV) and
trichomoniasis (TV) in pregnant women attending antenatal clinic at the Kintampo Municipal Hospital.
Methods: A study adopted a cross sectional design and recruited 589 pregnant women after seeking their
informed consent from September, 2014 to March, 2015. Semi-structured questionnaire were administered to
participants and vaginal swabs were collected. The samples were analysed using wet mount method and Gram
stain (Nugent criteria) for vaginal infection. Univariate and multivariate analysis were used to investigate association
of risk factors to vaginal infections.
Results: The overall prevalence of at least one vaginal infection was 56.4%. The prevalence of vulvovaginal
candidiasis, bacterial vaginosis and trichomoniasis were 36.5, 30.9 and 1.4% respectively. Women with more than
four previous pregnancies (OR: 0.27, 95% CI: 0.13–0.58) and those in the third trimester of pregnancy (OR: 0.54, CI:
0.30–0.96) were associated with a lower risk of bacterial vaginosis. Douching and antibiotic use were neither
associated with VVC or BV.
Conclusion: The prevalence of vaginal infections was high among pregnant women in the Kintampo area. There is
the need for interventions such as adequate investigations and early treatment of vaginal infections to reduce the
disease burden to avoid associated complications.
Background
Reproductive tract infection (ReTI) is an important pub-
lic health problem worldwide especially in developing
countries [1]. Globally, the World Health Organization
(WHO) reports an estimated 357 million new cases of
curable reproductive tract infection (ReTI) or sexually
transmitted infections (STIs) (syphilis, gonorrhea,
chlamydia infection, and trichomoniasis) which occur
annually in adults. These infections can be symptomatic
or asymptomatic [2]. Common symptoms reported are
vaginal discharge, itching, irritation, unpleasant odor and
discomfort. The main effect of ReTI on pregnancy is
preterm delivery [3, 4]. However, pelvic inflammatory
disease (PID), spontaneous abortion [5], low birth
weight, infertility, premature rupture of membrane
(PROM) and miscarriage [6] have also been linked with
BV. This study focused on the three most common ReTI
which include vulvovaginal candidiasis (VVC), bacterial
vaginosis (BV), and trichomoniasis (TV) which have
been association with poor pregnancy outcomes but
typically unattended to [3, 5, 6].
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VVC is caused by Candida spp commonly C. albicans,
C. glabrata and C. tropicalis [7]. Candida spp is asymp-
tomatic in about 20 to 50% of healthy women [8–10].
Vaginal colonization have been attributed to a number
of factors, including pregnancy, prolonged use of broad
spectrum antibiotics and poor personal hygiene [10]. BV
results from alterations of the normal flora in the vagina
mainly dominated by lactobacillus species to an over-
growth of anaerobic species [11–13]. BV is the common
cause of abnormal vaginal discharge in women of child
bearing age [14–16] with prevalence between 6 to 54%
[17–19]. Women with disrupted vaginal flora such as BV
are more likely to acquire other infections such as
herpes simplex virus type-2 (HSV-2) [15, 20], Trichomo-
nas vaginalis [21], Neisseria gonorrhoeae and human
immune deficiency virus (HIV) [22]. TV is caused by
Trichomonas vaginalis responsible for an estimated 180
million infections per year, making it the most prevalent
non-viral sexually transmitted pathogen worldwide [23].
The parasite is usually found in the vagina, cervix and
periurethral gland [24]. Approximately, 25% of women
with TV infection are asymptomatic [25]. Symptomatic
patients experience signs and symptoms such as vulvo-
vaginal erythema, dysuria, pruritus, edema, frothy yel-
low-gray or green vaginal discharge and an elevated pH
(> 6).
In Ghana, studies on prevalence of vaginal infection
were been carried out in urban settings where major-
ity of the population are educated [26–28]. Kintampo
a rural urban community, located in the middle belt
of Ghana with high illiteracy rate provides a good set-
ting to carry out ReTI studies to compare with that
of urban settings. This present study was conducted
to determine the prevalence of vaginal infection and
its associated risk factors.
Methods
Study site and study design
A descriptive cross-sectional survey was carried out in
the antenatal care unit (ANC) of the Kintampo Munici-
pal Hospital (KMH) between September 2014 and
March 2015. The KMH is located in the geographical
centre of Ghana. The hospital has an Antenatal Clinic
which serves, on average about 30 pregnant women each
working day. The KMH laboratory runs routine test for
the pregnant women, but the bacteriology work for this
study was carried out in the Kintampo Health Research
Centre (KHRC) Clinical Laboratory.
Study population, participant’s selection and recruitment
The surveys were carried out thrice a week and the first
eight to ten pregnant women in any trimester gave con-
sent to be part of the study during their antenatal visit
were enrolled into the study each day. The number
recruited per day was limited to allow for adequate ana-
lysis of samples collected. Women who had pregnancy
related complications or refused consent or had previ-
ously participated in the study were excluded from the
study.
Study procedure
After consent and recruitment, information on socio-
demographic variables, obstetric and sexual history,
symptoms of vaginal infection and reproductive risk
factors were obtained using a semi-structured pretested
questionnaire. As part of the study procedure, a trained
midwife examined the vulva and documented the pres-
ence of any abnormality including as genital warts,
genital ulcer, lesions and abnormal vaginal discharge.
Two swabs were taken under aseptic conditions by a
trained midwife from the posterior vaginal fornix. The
swabs were transported cold to Kintampo Health Re-
search Centre’s (KHRC) Clinical Laboratory within 10
min after sample collection. Samples are analyzed im-
mediately upon reaching the lab to avoid drying of the
specimen collected.
Laboratory test processes
Samples were processed at the Bacteriology section of
the Clinical Laboratory of KHRC. The Laboratory has a
good internal quality assurance system and also partici-
pates in an external quality assessment programme for
microbiology with National Institute of Communicable
Diseases in South Africa. A Gram stain smear was
prepared from one swab (labeled sample 1) then exam-
ined microscopically by qualified laboratory personnel
for BV diagnosis, using the Nugent’s scoring system
(Nugent’s criteria) [29]. A participant was declared posi-
tive for BV if her Nugent score was between 7 to 10 but
negative if less than 7. Ten percent of the smears were
re-read by another reader as quality control which was
in agreement with the first reader. The second swab
(labeled sample 2) from the same participant was also
used for wet mount preparation to identify yeast cells
(Budding/Pseudohyphae/Hyphae), pus cell, clue cells
and Trichomonas vaginalis. The wet mount procedure
involves adding few drops of normal saline to the swab,
shaking gently to mix sample with the saline. A drop
was placed on a glass slide, cover slipped and observed
with X100 and X400 magnification.
The laboratory personnel were blinded to the clinical
findings of the participants, or any other details, except
participants’ study numbers and specimen collection
dates.
Samples size estimation
A sample size of 606 was obtained based on a reported
6.4% prevalence of BV among pregnant women attending
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ANC in Burkina Faso [17]. A higher prevalence of 10%
BV was assumed in a predominantly rural setting such as
Kintampo with 90% power and 95% confidence level
taking into account 5% refusals the sample size pro-
vided 93 and 94% power to estimate the prevalence of
VVC and TV respectively. The power was calculated
using a known prevalence of 34.2% (VVC) and 1.4%
(TV) in women attending gyaenacological and antenatal
clinic in Accra, Ghana [30]. An assumed prevalence of
41 and 3.5% for VVC and TV was respectively used in
the calculations.
Data collection, management and analysis
Data were double entered using MS-access software
(Microsoft Corporation Copyright 2003) and checked
for consistencies. Data was analysed using STATA
Version 14 (Stata Corp, TX USA). All categorical vari-
ables were summarized as proportions whilst continu-
ous variables were summarized as means or median
based on the distribution of the variables. Associations
between categorical variables were explained using the
chi-square test P < 0.05 was considered significant.
Univariate and multivariate logistic regression models
were used to identify potential risk factors of VVC and
BV but not TV due to the low numbers identified. We
assessed the association between BV, VVC and both
BV and VVC infection with reported symptoms using
the chi-square test.
Results
Characteristics of study participants
A total of 606 pregnant women were contacted to partici-
pate in the study but 97.9% (593/606) gave consent. The
remaining 13 participants refused to consent to participate
in the study. Out of the 593 consented participants, 589
had complete data on their demographics and vaginal sam-
ples whiles 4 participants gave information on only their
demographic but refused vaginal swab collection. Demo-
graphic and obstetric characteristics of the participants are
summarized in Table 1. The mean age of the women was
27 years (N = 593, range 12 to 54 years). Married women,
Christians and employment status of participants were
68.8% (408/593), 65.6% (389/593) and 62.6% (371/593)
respectively. Slightly above half of the participants had com-
pleted primary or Junior High School 52.5% (311/593) and
in the second trimester of pregnancy 53.3% (316/593).
Prevalence of VVC, BV and TV
The prevalence of VVC, BV and TV among the pregnant
women were 36.5% (215/589), 30.9% (182/589) and 1.4%
(8/589) respectively. The prevalence of at least one of
the three vaginal infections (VVC or BV or TV) was
56.4% (332/589) (Fig. 1).
Table 1 Characteristics of study participants
Characteristics N = 593 n (%)
Age group
< 19 77 (13.0)
20–34 423 (71.3)
> 35 92 (15.5)
Missing 1 (0.002)
Marital Status
Single 96 (16.2)
Cohabiting 88 (14.8)
Married 408 (68.8)
Missing 1 (0.002)
Religion
Christians 389 (65.6)
Muslim 188 (31.7)
Others 16 (2.7)
Occupation
Employed 371 (62.6)
Unemployed 222 (37.4)
Education
No education 211 (35.6)
Primary & JHS 311 (52.5)
> SHS 71 (12.0)
Trimester
First 81 (13.7)
Second 316 (53.3)
Third 196 (33.1)
Gravidae
Primigravidae 145 (24.5)
2–4 gravidae 317 (53.5)
5 gravidae 131 (22.1)
History of spontaneous abortion
Yes 99 (16.7)
No 494 (83.3)
Contraceptive Use
Yes 168 (28.3)
No 425 (71.7)
Douching
Yes 219 (36.9)
No 374 (63.1)
Antibiotic use in the past 2 weeks
Yes 26 (4.4)
No 567 (95.6)
Sex frequency
< 2 per week 424 (71.4)
> 2 per week 170 (28.6)
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Risk factors for vulvovaginal candidiasis (VVC) and
bacterial vaginosis (BV)
In VVC, univariate and multivariate were not signifi-
cantly associated with all possible risk factors in the ana-
lysis (Table 2).
For BV, univariate analysis (Table 3) of marital status
(single and cohabiting), primary & JHS education, occu-
pation were independent risk factor for BV whiles age
group (20–34, > 35), third trimester of pregnancy and
multigravidae were associated with a lower risk. Douch-
ing, recent antibiotic use and sex frequency were not
significant risk factors for BV. In multivariate analysis,
only pregnant women in the third trimester of preg-
nancy and previous pregnancy of more than 4 were pro-
tective for bacterial vaginosis.
Association between vaginal infection and reported
symptoms
Self-reported symptoms of vaginal infection were all sig-
nificantly associated with vaginal infection using the chi-
squared test (Table 4).
Discussion
VVC was documented as the highest vaginal infection
with prevalence rate of 36.5% in this study. The reported
rate among pregnant women compares well with 34.2%
in Accra, 36.0% in Southwestern Nigeria, 37.4% in
Turkey [27, 31, 32]. However, in other studies conducted
among pregnant women, the prevalence found in the
present study was slightly higher than 26.0 and 30% in
Ibadan and Newi Town of Anambra State both in
Nigeria [9, 33]. A lower rate of 21% was recorded in
Kumasi among women attending gynecological clinic
[34] and 22.7% in pregnant women in Burkina Faso [35].
The lower rate of 21% reported by Abruquah et al. [34],
study might be due to the small sample size of partici-
pants compared with the present study.
In another related study among pregnant women in
the United Kingdom, Candida spp prevalence was 12.5%
as compared to 36.5% in this study [36]. This disparity
in the prevalence might be due lack of proper sanitary
conditions in many rural communities such as Kintampo
compared to the United Kingdom. Risk factors for the
infection and local population dynamics accounts for the
huge disparities in the prevalence rate across countries.
The high Candida spp colonization/infection of the
study participants’ vagina could have been due to their
pregnancy status. Although, about 20 to 50% of women
habour candida species without showing symptoms [7],
pregnancy plays a major role in colonization and infec-
tion. Leli et al., study demonstrates frequent colonization
of the vagina of pregnant women with Candida spp
compared to non-pregnant women [37]. This is as a
result of the high concentration of estrogen during preg-
nancy which provides a favourable environment for the
growth of Candida spp [38]. Nonetheless, this high rate
calls for urgent attention to the infection since studies
suggest possible association between Candida spp
colonization and higher rate of preterm and low birth
Table 1 Characteristics of study participants (Continued)
Characteristics N = 593 n (%)
New sexual partners in the past 3 months
Yes 1 (0.002)
No 588 (99.8)
Presence of abnormal vaginal discharge
Yes 166 (28.2)
No 423 (71.8)
Genital Warts
Yes 5 (0.8)
No 584 (99.2)
Fig. 1 Prevalence of the vaginal infections among pregnant women (N = 589)
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Table 2 Risk factors for vulvovaginal candidiasis (VVC)
VVC OR
(Unadjusted)
P-value for OR AOR
(Adjusted)
P-value for AOR
Yes n (%) No n (%)
Age group
< 19 25 (32.1) 53 (67.9) 1.0 –
20–34 158 (37.4) 264 (62.6) 1.27 (0.76–2.12) 0.365 – –
35+ 32 (36.0) 57 (64.0) 1.19 (0.63–2.26) 0.596 – –
Marital Status
Married 149 (36.9) 255 (63.1) 1.0 –
Single 35 (36.1) 62 (63.9) 0.97 (0.61–1.53) 0.884 – –
Cohabiting 31 (35.2) 57 (64.8) 0.93 (0.57–1.50) 0.770 – –
Religion
Christians 143 (36.9) 245 (63.1) 1.0 –
Muslim 63 (34.1) 122 (65.9) 0.88 (0.63–1.28) 0.514 – –
Others 9 (56.3) 7 (43.8) 2.20 (0.80–6.04) 0.125 – –
Education
No education 80 (37.9) 131 (62.1) 1.0 –
Primary & JHS 112 (36.2) 197 (63.8) 0.93 (0.65–1.33) 0.699 – –
> SHS 23 (33.3) 46 (66.7) 0.82 (0.46–1.45) 0.494 – –
Occupation
Unemployed 73 (32.7) 150 (67.3) 1.0 –
Employed 142 (38.8) 224 (61.2) 0.77 (0.54–1.09) 0.139 – –
Trimester
First 30 (36.1) 53 (63.9) 1.0 –
Second 110 (34.8) 206 (65.2) 0.94 (0.57–1.56) 0.821 – –
Third 75 (39.5) 115 (60.5) 1.15 (0.67–1.96) 0.603 – –
Gravidae
Primigravidae 46 (31.9) 96 (68.1) 1.0 –
2–4 gravidae 123 (39.2) 191 (60.8) 1.37 (0.90–2.08) 0.137 – –
5 gravidae 46 (35.1) 85 (64.9) 1.15 (0.70–1.90) 0.578 – –
History of spontaneous abortion
No 176 (35.8) 315 (64.2) 1.0 –
Yes 39 (39.8) 59 (60.2) 1.18 (0.76–1.85) 0.459 – –
Contraceptive use before Pregnancy
No 152 (36.0) 270 (64.0) 1.0 –
Yes 63 (37.7) 104 (62.3) 1.07 (0.74–1.56) 0.698 – –
Douche
No 136 (36.7) 235 (63.3) 1.0 –
Yes 79 (36.2) 139 (63.8) 0.9 (0.69–1.39) 0.919 – –
Antibiotic use
No 202 (35.9) 361 (64.1) 1.0 –
Yes 13 (50.0) 13 (50.0) 1.79 (0.83–3.93) 0.149 – –
Sex Frequency
< 2 per week 161 (38.3) 259 (61.7) 1.0 –
> 2 per week 54 (32.0) 115 (68.1) 0.76 (0.52–1.10) 0.146 – –
Trichomoniasis
No 211 (36.3) 370 (63.7) 1.0 –
Yes 4 (50.0) 4 (50.0) 1.75 (0.43–7.08) 0.430 – –
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Table 3 Risk factors for BV
BV Status OR
(Unadjusted)
P-value AOR (Adjusted) P-value for AOR
Yes n (%) No n (%)
Age group
< 19 36 (46.2) 42 (53.8) 1.0 1.0
20–34 128 (30.3) 294 (69.7) 0.51 (0.31–0.83) 0.007 0.93 (0.51–1.68) 0.802
35+ 18 (20.2) 71 (79.8) 0.30 (0.14–0.59) < 0.001 1.02 (0.42–2.43) 0.969
Marital Status
Married 103 (25.5) 301 (74.5) 1.0 1.0
Single 45 (46.4) 52 (53.6) 2.53 (1.60–4.00) < 0.001 1.60 (0.94–2.71) 0.083
Cohabiting 34 (38.6) 54 (61.4) 1.84 (1.13–2.99) 0.014 1.41 (0.84–2.35) 0.189
Religion
Christians 127 (32.7) 261 (67.3) 1.0 –
Muslim 48 (26.0) 137 (74.0) 0.72 (0.48–1.06) 0.100 – –
Others 7 (43.7) 9 (56.3) 1.60 (0.58–4.39) 0.363 – –
Education
No education 52 (24.6) 159 (75.4) 1.0 1.0
Primary & JHS 110 (35.6) 199 (64.4) 1.69 (1.14–2.50) 0.008 1.17 (0.76–1.79) 0.473
> SHS 20 (71.0) 49 (29.0) 1.24 (0.68–2.29) 0.474 0.80 (0.41–1.55) 0.503
Occupation
Unemployed 84 (37.7) 139 (62.3) 1.0 1.0
Employed 98 (26.8) 268 (73.2) 1.65 (1.16–2.36) 0.006 0.98 (0.64–1.50) 0.940
Trimester
First 31 (37.3) 52 (62.7) 1.0 1.0
Second 104 (32.9) 212 (67.1) 0.82 (0.50–1.36) 0.447 0.80 (0.47–1.34) 0.395
Third 47 (24.7) 143 (75.3) 0.55 (0.32–0.96) 0.035 0.54 (0.30–0.96) 0.035
Gravidae
Primigravidae 64 (44.4) 80 (55.6) 1.0 1.0
2–4 gravidae 99 (31.5) 215 (68.5) 0.58 (0.38–0.86) 0.008 0.67 (0.41–1.10) 0.114
5 gravidae 19 (14.5) 112 (85.5) 0.21 (0.12–0.38) < 0.001 0.27 (0.13–0.58) 0.001
History of spontaneous abortion
No 158 (32.2) 333 (67.8) 1.0 –
Yes 24 (24.5) 74 (75.5) 0.68 (0.42–1.12) 0.134 – –
Contraceptive use before present Pregnancy
No 139 (32.9) 283 (67.1) 1.0 –
Yes 43 (25.7) 124 (74.3) 0.71 (0.47–1.06) 0.090 – –
Douche
No 119 (32.1) 252 (67.9) 1.0 –
Yes 63 (28.9) 155 (71.1) 0.86 (0.60–1.24) 0.421 – –
Antibiotic use
No 171 (30.4) 392 (69.6) 1.0 –
Yes 11 (42.3) 15 (57.7) 1.68 (0.76–3.74) 0.202 – –
Sex Frequency
< 2 per week 130 (31.9) 290 (69.1) 1.0 –
> 2 per week 52 (30.8) 117 (69.2) 0.99 (0.67–1.46) 0.965 – –
Trichomoniasis
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weight [37, 39]. Screening for VVC during pregnancy
may reduce the risk of preterm delivery [40, 41]. More-
over, symptomatic cases of VVC could cause a lot of
discomfort to pregnant women. VVC could also be an
indication of an underlying infection such as diabetes
mellitus.
The prevalence of BV (30.9%) in pregnant women
reported in this study was higher compared with that
(1.4%) reported by Apea-Kubi et al., in 2006 among
women attending antenatal and gynaecological clinic in
Accra [27]. However, it was comparable to a prevalence
of 28.0% reported among non-pregnant women in the
coastal area of Ghana [42]. Lassey et al., in 2004 reported
a prevalence of 47.0% among women with incomplete
abortion in Accra [43]. This high rate was probably due
to the complication of the abortion which could alter
the normal flora of the vagina. Pepin et al., 2011 re-
ported an aggregate rate of 54% on women presenting
with vaginal discharge in five West African states includ-
ing Ghana [18]. This high rate is due to the study’s
selection of women with vaginal discharge which is
usually a symptom of vaginal infection. In addition, the
study used molecular method which is highly sensitive
compared to the Nugent criteria for the diagnoses of BV.
In other West African states, the prevalence of BV of
64.3, 17.3 and 6.4% were reported in Southwestern-
Nigeria [44], Northeastern-Nigeria [45] and Burkina Faso
[19] respectively in pregnant women. Geographical distri-
bution, vaginal hygiene practices and systematic difference
in the various populations sampled could account for the
variation in the prevalence values. Douching which has
been known to be a major risk factor to BV in several
cross-sectional and longitudinal studies [46–48] was not
associated with BV in this study. This finding is consistent
with Demba et al., 2005 and Bukusi et al., 2006 studies
which showed no significant relationship between BV and
douching [49, 50]. Douching alters the pH of the vagina
due to the depletion of lactic acid producing lactobacillus
depending on the type of douching solution used.
Prevalence of Trichomonas infection was the lowest
(1.4%) compared to the other vaginal infections. Generally,
the prevalence of TV found in this study is lower than other
studies conducted in Ghana among pregnant women.
Apea-Kubi et al., and Adu-Sakordie et al., reported
prevalence rates of 2.7% [27] and 5.4% [26] respectively
among pregnant women. In the study by Adu-Sakordie et
al., a more sensitive latex agglutination kit was used com-
pared to wet mount used in this study. Low rates of TV
were recorded in Nigeria (0.5%), Burkina (1.5%) among
pregnant women which is of similar finding to this study
[17, 51]. Some other studies in women visiting gynaeco-
logical and STI clinics recorded rates of 13.2 and 18.1% by
wet mount method and polymerase chain reaction (PCR)
respectively for TV [28]. This high rate is due to the selec-
tion of women visiting STI clinic for treatment of symp-
toms of vaginal infection.
The low prevalence of TV in the present study may be
attributed to the test method used for this study. A study
by Richard Asmah et al., concluded wet mount method
had very low sensitivity in detecting TV using (PCR) as
the gold standard [28, 52]. Collins Adjei et al., study
among symptomatic participants recorded prevalence of
1.7, 5.0 and 7.2% with wet mount, culture and enzyme-
linked immunosorbent assay (ELISA) methods respect-
ively [53]. These studies confirm the low sensitivity of
the wet mount method which could have accounted for
the low prevalence of TV in this study. The time be-
tween samples collection and analysis could affect the
likelihood of detecting TV. In this study, the time
between sample collection and analysis was within the
recommended 15min, ruling out the possibility of time
playing a role in the low prevalence of TV.
Sexual behavior of the participants which is the main
determinant of trichomoniasis may be a factor for the
low rate. This is evident in the fact that only one out of
the 593 participants interviewed reported having more
than one sexual partner in the past 3 months (Table 1).
In addition, majority of the participants were married
and may not be likely to have multiple sexual partner
compared to studies in sex workers.
The study assessed the risk factors for the vaginal in-
fections. After adjusting for other confounding variable,
having previous pregnancies of 5 or more (>gravidae 5)
(p = 0.001) lowered the risk of BV. The protection ob-
served among multigravida women (5 or more) against
BV could be due to health education provided during
antenatal visits and personal experiences of these 131
pregnant women (Table 1) in previous pregnancies.
Table 3 Risk factors for BV (Continued)
BV Status OR
(Unadjusted)
P-value AOR (Adjusted) P-value for AOR
Yes n (%) No n (%)
No 179 (30.8) 402 (69.2) 1.0 –
Yes 3 (37.5) 5 (62.5) 1.35 (0.32–5.70) 0.685 – –
Candidiasis
No 115 (30.7) 259 (69.3) 1.0 –
Yes 67 (31.2) 148 (68.8) 1.02 (0.71–1.47) 0.917 – –
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Pregnant women in the third trimester were 35 and
53% less likely to have BV (Table 3) compared with the
second and first trimesters respectively. BV appeared to
decrease with increasing gestational age. This finding is
consistent with Water et al., 2008 study which reported
BV status decreases as pregnancy progresses [54]. Stud-
ies have shown reduced sexual desire and sexual activity
as pregnancy ages [55, 56], which indicates reduced sex-
ual frequency. Frequency of sexual intercourse is attrib-
uted to be a critical factor to having BV [57] which
might account for the decreased BV prevalence with ges-
tational age.
Risk factors considered for VVC and TV in this study
were not significantly associated with VVC or TV (P >
0.05). Studies have shown recent antibiotic intake and
douching to have a positive correlation to VVC [58].
This happens when antibiotic/douching substance kills
or suppresses the Lactobacillus species which serves as a
protective organism making way for the yeast to thrive
and colonise the vagina. This negative correlation be-
tween antibiotic use and VVC in the present study could
be because of the low level of antibiotic intake (4.4%) by
the study participants as shown in Table 1.
Asymptomatic participants (Table 4) comprised of
more than half of those who tested for BV only (55.7%)
and VVC only (68.2%). This highlights the inadequacy of
using syndromic management in treating patients. It
stresses the importance of testing to know the aetiologic
agent as opposed to managing using syndromic ap-
proach. Testing to know the aetiologic agent is hindered
in many less resourced countries due to lack of adequate
laboratory infrastructure.
There have been issues of the need to treat or not to
treat asymptomatic vaginal infection in pregnant women
arising out of conflicting findings of the benefits or
otherwise of the treatment. Many studies have link BV
and Candida spp colonization to adverse pregnancy out-
comes [5, 6]. Unraveling this mystery requires further
large scale longitudinal and follow up studies to establish
the effect of vaginal infections in pregnancy.
The study’s limitation was the use wet mount method
to detection of TV for the study compared with more
sensitive method such as PCR. The wet mount method
used played a role in the low prevalence of TV. How-
ever, some studies had high prevalence for TV using the
wet mount method [28] which might be due to the
population of women for which the study was carried
out on.
Conclusion and recommendations
The study area had very high prevalence of vaginal infec-
tions among pregnant women especially VVC and BV.
Having more than four (4) previous pregnancies and in
the third trimester of pregnancy lowered the risk for
having BV.
Considering the high prevalence of vaginal infections,
we recommend that pregnant women attending ante-
natal clinic should have prompt and adequate laboratory
investigations with appropriate treatment to prevent
possible adverse effect of the infection on mother and/or
foetus.
The uncertainty surrounding how the infection affects
the mother and foetus need to be investigated. Therefore,
further longitudinal and follow-up studies to investigate
the effects of vaginal infections on pregnancy outcomes
are recommended.
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Table 4 Association between symptom and laboratory
confirmed vaginal infection
Symptoms Infection P-value
No infection
(n = 259)
BV only
(n = 115)
VVC only
(n = 148)
BV and VVC
(n = 67)
Abdominal pain
Present 52 (20.08) 30 (26.09) 28 (18.92) 27 (40.30) 0.002
Absent 207 (79.92) 85 (73.91) 120 (81.08) 40 (59.70)
Pruritis
Present 46 (17.76) 34 (29.57) 35 (23.65) 27 (40.30) 0.001
Absent 213 (82.24) 81 (70.43) 113 (76.35) 40 (59.70)
Malodour
Present 55 (21.24) 33 (28.70) 25 (16.89) 22 (32.84) 0.025
Absent 204 (78.76) 82 (71.30) 123 (83.11) 45 (67.16)
Dysuria
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Altered discharge
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No 170 (65.64) 64 (55.65) 101 (68.24) 26 (38.81)
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